Correlation Between Avadel Pharmaceuticals and Valens

Can any of the company-specific risk be diversified away by investing in both Avadel Pharmaceuticals and Valens at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Avadel Pharmaceuticals and Valens into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Avadel Pharmaceuticals PLC and Valens, you can compare the effects of market volatilities on Avadel Pharmaceuticals and Valens and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Avadel Pharmaceuticals with a short position of Valens. Check out your portfolio center. Please also check ongoing floating volatility patterns of Avadel Pharmaceuticals and Valens.

Diversification Opportunities for Avadel Pharmaceuticals and Valens

-0.28

Correlation Coefficient

Avadel Pharmaceuticals  Valens

Very good diversification

The 3 months correlation between Avadel and Valens is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Avadel Pharmaceuticals PLC and Valens in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Valens and Avadel Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Avadel Pharmaceuticals PLC are associated (or correlated) with Valens. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Valens has no effect on the direction of Avadel Pharmaceuticals i.e., Avadel Pharmaceuticals and Valens go up and down completely randomly.

Pair Corralation between Avadel Pharmaceuticals and Valens

Given the investment horizon of 90 days Avadel Pharmaceuticals PLC is expected to under-perform the Valens. In addition to that, Avadel Pharmaceuticals is 1.04 times more volatile than Valens. It trades about -0.05 of its total potential returns per unit of risk. Valens is currently generating about -0.04 per unit of volatility. If you would invest  218.00  in Valens on September 23, 2024 and sell it today you would lose (34.00) from holding Valens or give up 15.6% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Avadel Pharmaceuticals PLC  vs.  Valens

Avadel Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Avadel Pharmaceuticals PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's fundamental indicators remain quite persistent which may send shares a bit higher in January 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Valens

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Valens has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unsteady performance, the Stock's essential indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors.

Pair Trading with Avadel Pharmaceuticals and Valens

The main advantage of trading using opposite Avadel Pharmaceuticals and Valens positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Avadel Pharmaceuticals position performs unexpectedly, Valens can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Valens will offset losses from the drop in Valens' long position.

The idea behind Avadel Pharmaceuticals PLC and Valens pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.